Reboxetine versus other antidepressive agents for depression
Churchill R., Caldwell DM., McGuire H., Barbui C., Cipriani A., Furukawa TA., Watanabe N., Lewis G.
The planned review outlined in this protocol has not been successfully converted into a full Cochrane Review within established timelines and for this reason has been withdrawn by the Common Mental Disorders CRG from the CDSR.